Treatment of acute hypercalcemia

Medicinal Chemistry

Volumn 8, Issue 4, 2012, Pages 564-568

  Basso, Stafano M M ^a   Lumachi, Franco ^b   Nascimben, Fabiana ^a   Luisetto, Giovanni ^b   Camozzi, Valentina ^b  

^a S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Acute hypercacemia; Bone resorption; Hypercalcemia; Hypercalcemic crisis; Normovolmia

Indexed keywords

CALCITONIN; CALCIUM; FUROSEMIDE; GALLIUM NITRATE; HYDROCORTISONE; IBANDRONIC ACID; MITHRAMYCIN; PAMIDRONIC ACID; PREDNISONE; SODIUM CHLORIDE; ZOLEDRONIC ACID;

ARTERIAL PRESSURE; ARTICLE; BLOOD VOLUME; CALCIUM ABSORPTION; CALCIUM EXCRETION; DEHYDRATION; DIALYSIS; DIURESIS; EVIDENCE BASED PRACTICE; HEART ARRHYTHMIA; HUMAN; HYPERCALCEMIA; KIDNEY FUNCTION; MENTAL HEALTH; NAUSEA; OSTEOCLAST; OSTEOLYSIS; OXYGEN SATURATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REHYDRATION; TEMPERATURE; URINARY EXCRETION; VOMITING;

ACUTE DISEASE; BONE DENSITY CONSERVATION AGENTS; DECISION SUPPORT TECHNIQUES; DIPHOSPHONATES; HUMANS; HYPERCALCEMIA;

EID: 84863741401     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/157340612801216382     Document Type: Article

References (20)

1. Edelson, G. W.; Kleerekoper, M. Hypercalcemic crisis. Med. Clin. North. Am., 1995, 79, 79-92.
2. Ziegler, R. Hypercalcemic crisis. J. Am. Soc. Nephrol., 2001, 12, S3-S9.
3. Grill, V.; Martin, T. J. Hypercalcemia of malignancy. Rev. Endocr. Metabol. Disord., 2000, 1, 253-263.
4. Stewart, A. F. Clinical practice. Hypercalcemia associated with cancer. N. Engl. J. Med., 2005, 352, 373-379.
5. Lumachi, F.; Basso, S. M. M.; Orlando, R. Cytokines, thyroid disease and thyroid cancer. Cytokine, 2010, 50, 229-233.
6. Lumachi, F.; Brunello, A.; Roma, A.; Basso, U. Cancer-induced hypercalcemia. Anticancer Res., 2009, 29, 1551-1556.
7. DeLellis, R. A.; Xia, L. Paraneolastic endocrine sindrome: a review. Endocr. Pathol., 2003, 14, 303-318.
8. Clines, G. A.; Guise, T. A. Hypercalcemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone. Endocr. Relat. Cancer, 2005, 12, 549-583.
9. Nascimben, F. In: Hypercalcemia. Pathophysiology and treatment; Lumachi, F.; Basso, S. M. M., Eds.; Bentham Sciences: Sharjah (UAE), 2010; pp. 38-44.
10. Assadi, F. Hypercalcemia: an evidence-based approach to clinical cases. Iran J. Kidney Dis., 2009, 3, 71-79.
11. Binstock, M. L.; Mundy, G. R. Effect of calcitonin and glucocorticoids in combination on the hypercalcemia of malignancy. Ann. Intern. Med., 1980, 93, 269-272.
12. Cannon, J.; Lew, J. L.; Solòrzano, C. C. Parathyroidectomy for hypercalcemic crisis: 40 years' experience and long-term outcomes. Surgery, 2010, 148, 807-812.
13. Lumachi, F.; Brunello, A.; Roma, A.; Basso, U. Medical treatment of malignancy-associated hypercalcemia. Curr. Med. Chem., 2008, 15, 415-421.
14. Samphao, S.; Eremin, J. M.; Eremin, O. Oncological emergencies: clinical importance and principles of management. Eur. J. Cancer Care, 2010, 19, 707-713.
15. Ralston, S. H.; Coleman, R.; Fraser, W. D.; Gallagher, S. J.; Hosking, D. J.; Iqbal, J. S.; McCloskey, E.; Sampson, D. Medical management of hypercalcemia. Calcif. Tissue Int., 2004, 74, 1-11.
16. Lameire, N.; Van Biesen, W.; Vanholder, R. Electrolyte disturbances and acute kidney injury in patients with cancer. Semin. Nephrol., 2010, 30, 534-547.
17. Ross, J. R.; Saunders, Y.; Edmonds, P. M.; Patel, S.; Broadley, K. E.; Johnston, S. R. Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer. BMJ, 2003, 327, 469-471.
18. Saunders, Y.; Ross, J. R.; Broadley, K. E.; Edmonds, P. M.; Patel, S. Systematic review of bisphosphonates for hypercalcemia of malignancy. Palliative Medicine, 2004, 18, 418-431.
19. Body, J. J.; Dumon, J. C. Treatment of tumour-induced hypercalcaemia with the bisphosphonate pamidronate: dose-response relationship and influence of tumour type. Ann. Oncol., 1994, 5, 359-363.
20. Body, J. J.; Lortholary, A.; Romieu, G.; Vigneron, A. M.; Ford, J. A dose-finding study of zoledronate in hypercalcemic cancer patients. J. Bone Miner. Res., 1999, 14, 1557-1561.